Sébastien Moutton

Sébastien Moutton

Auto-generated profile, based on publicly available information

Sébastien Moutton

CPDPN, Pôle mère enfant, Maison de Santé Protestante Bordeaux Bagatelle , Talence 33522

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2015 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
DMDennis Mircsof
Dennis Mircsof
MLMaéva Langouët
Maéva Langouët
MRMarlène Rio
Marlène Rio
SMSébastien Moutton
Sébastien Moutton
KSKarine Siquier-Pernet
Karine Siquier-Pernet
LCLaurence Colleaux
Laurence Colleaux

24 April 2013 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
LMLionel Van Maldergem
Lionel Van Maldergem
QHQingming Hou
Qingming Hou
VKVera Kalscheuer
Vera Kalscheuer
MRMarlène Rio
Marlène Rio
MDMartine Doco-Fenzy
Martine Doco-Fenzy
HMHeng-Ye Man
Heng-Ye Man
Existence of a discrete new X-linked intellectual disability (XLID) syndrome due to KIAA2022 deficiency was questioned by disruption of KIAA2022 by an X-chromosome pericentric inversion in a XLID family we reported in 2004. Three additional families with likely pathogenic KIAA2022 mutations were discovered within the frame of systematic parallel sequencing of familial cases of XLID or in the context of routine array-CGH evaluation of sporadic intellectual deficiency (ID) cases. The c.186delC and c.3597dupA KIAA2022 truncating mutations were identified by X-chromosome exome sequencing, while array CGH discovered a 70 kb microduplication encompassing KIAA2022 exon 1 in the third family. This duplication decreased KIAA2022 mRNA level in patients' lymphocytes by 60%. Detailed clinical examination of all patients, including the two initially reported, indicated moderate-to-severe ID with autistic features, strabismus in all patients, with no specific dysmorphic features other than a round face in infancy and no structural brain abnormalities on magnetic resonance imaging (MRI). Interestingly, the patient with decreased KIAA2022 expression had only mild ID with severe language delay and repetitive behaviors falling in the range of an autism spectrum disorder (ASD). Since little is known about KIAA2022 function, we conducted morphometric studies in cultured rat hippocampal neurons. We found that siRNA-mediated KIAA2022 knockdown resulted in marked impairment in neurite outgrowth including both the dendrites and the axons, suggesting a major role for KIAA2022 in neuron development and brain function.

20 August 2015 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
JPJulie Pilliod
Julie Pilliod
SMSébastien Moutton
Sébastien Moutton
JLJulie Lavie
Julie Lavie
EMElise Maurat
Elise Maurat
CHChristophe Hubert
Christophe Hubert
ICIsabelle Coupry
Isabelle Coupry

8 July 2015 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
LNLam Son Nguyen
Lam Son Nguyen
TSTaiane Schneider
Taiane Schneider
MRMarlène Rio
Marlène Rio
SMSébastien Moutton
Sébastien Moutton
KSKarine Siquier-Pernet
Karine Siquier-Pernet
LCLaurence Colleaux
Laurence Colleaux
Megalencephaly is a congenital condition characterized by severe overdeveloped brain size. This phenotype is often caused by mutations affecting the RTK/PI3K/mTOR (receptor tyrosine kinase-phosphatidylinositol-3-kinase-AKT) signaling and its downstream pathway of mammalian target of rapamycin (mTOR). Here, using a whole-exome sequencing in a Moroccan consanguineous family, we show that a novel autosomal-recessive neurological condition characterized by megalencephaly, thick corpus callosum and severe intellectual disability is caused by a homozygous nonsense variant in the HERC1 gene. Assessment of the primary skin fibroblast from the proband revealed complete absence of the HERC1 protein. HERC1 is an ubiquitin ligase that interacts with tuberous sclerosis complex 2, an upstream negative regulator of the mTOR pathway. Our data further emphasize the role of the mTOR pathway in the regulation of brain development and the power of next-generation sequencing technique in elucidating the genetic etiology of autosomal-recessive disorders and suggest that HERC1 defect might be a novel cause of autosomal-recessive syndromic megalencephaly.

1 June 2017 in Genetics in Medicine
Verified
Journal Article
Open access
LGLivia Garavelli
Livia Garavelli
IIIvan Ivanovski
Ivan Ivanovski
SCStefano Giuseppe Caraffi
Stefano Giuseppe Caraffi
DSDaniela Santodirocco
Daniela Santodirocco
MPMarzia Pollazzon
Marzia Pollazzon
APAlex R Paciorkowski
Alex R Paciorkowski
Mowat-Wilson syndrome (MWS) is a genetic disease characterized by distinctive facial features, moderate to severe intellectual disability, and congenital malformations, including Hirschsprung disease, genital and eye anomalies, and congenital heart defects, caused by haploinsufficiency of the ZEB2 gene. To date, no characteristic pattern of brain dysmorphology in MWS has been defined. Through brain magnetic resonance imaging (MRI) analysis, we delineated a neuroimaging phenotype in 54 MWS patients with a proven ZEB2 defect, compared it with the features identified in a thorough review of published cases, and evaluated genotype-phenotype correlations. Ninety-six percent of patients had abnormal MRI results. The most common features were anomalies of corpus callosum (79.6% of cases), hippocampal abnormalities (77.8%), enlargement of cerebral ventricles (68.5%), and white matter abnormalities (reduction of thickness 40.7%, localized signal alterations 22.2%). Other consistent findings were large basal ganglia, cortical, and cerebellar malformations. Most features were underrepresented in the literature. We also found ZEB2 variations leading to synthesis of a defective protein to be favorable for psychomotor development and some epilepsy features but also associated with corpus callosum agenesis. This study delineated the spectrum of brain anomalies in MWS and provided new insights into the role of ZEB2 in neurodevelopment.Genet Med advance online publication 10 November 2016.

1 October 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
FPFélixe Pelletier
Félixe Pelletier
SPStefanie Perrier
Stefanie Perrier
FCFerdy K Cayami
Ferdy K Cayami
AMAmytice Mirchi
Amytice Mirchi
SSStephan Saikali
Stephan Saikali
GBGeneviève Bernard
Geneviève Bernard
Context 4H or POLR3-related leukodystrophy is an autosomal recessive disorder typically characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism, caused by biallelic pathogenic variants in POLR3A, POLR3B, POLR1C, and POLR3K. The endocrine and growth abnormalities associated with this disorder have not been thoroughly investigated to date. Objective To systematically characterize endocrine abnormalities of patients with 4H leukodystrophy. Design An international cross-sectional study was performed on 150 patients with genetically confirmed 4H leukodystrophy between 2015 and 2016. Endocrine and growth abnormalities were evaluated, and neurological and other non-neurological features were reviewed. Potential genotype/phenotype associations were also investigated. Setting This was a multicenter retrospective study using information collected from 3 predominant centers. Patients A total of 150 patients with 4H leukodystrophy and pathogenic variants in POLR3A, POLR3B, or POLR1C were included. Main Outcome Measures Variables used to evaluate endocrine and growth abnormalities included pubertal history, hormone levels (estradiol, testosterone, stimulated LH and FSH, stimulated GH, IGF-I, prolactin, ACTH, cortisol, TSH, and T4), and height and head circumference charts. Results The most common endocrine abnormalities were delayed puberty (57/74; 77% overall, 64% in males, 89% in females) and short stature (57/93; 61%), when evaluated according to physician assessment. Abnormal thyroid function was reported in 22% (13/59) of patients. Conclusions Our results confirm pubertal abnormalities and short stature are the most common endocrine features seen in 4H leukodystrophy. However, we noted that endocrine abnormalities are typically underinvestigated in this patient population. A prospective study is required to formulate evidence-based recommendations for management of the endocrine manifestations of this disorder.